Emcure Pharma shares up 5% after Jefferies initiates 'Buy' rating 

Open Demat A/C

Jefferies sets ₹1,600 target for Emcure Pharma, indicating a 15% upside potential

Open Demat A/C

Emcure Pharma stock is up 40% from the issue price of ₹1,008

Open Demat A/C

Emcure Pharma shares surge 5% to record high of ₹1,455.20 following 'Buy' rating

Open Demat A/C

Emcure Pharma projects 11% annual revenue growth and 29% profit CAGR from FY24 to FY27

Open Demat A/C

Emcure Pharma achieves 11% revenue growth in FY24, reaching ₹6,715 crore

Open Demat A/C

Emcure Pharma FY24 profit falls 6% to ₹527 crore, down from ₹561 crore

Open Demat A/C

With Our Subscription Plans

Open demat account in 5 minutes*

Open Demat A/C
G-L92HWH8MZR